[IMCAS World 2026 Special] Shaping the Future: K-Medical Aesthetics Leading Innovation ⑪ | Interview with Hauke Harms, President of International, Cynosure Lutronic
Cynosure Lutronic—born from the merger of two global leaders in the energy-based aesthetic device (EBD) market, Cynosure and Lutronic—unveiled three new products at IMCAS World Congress 2026, declaring a "Year of Innovation." The lineup includes the non-invasive fractional laser Mosaic 3D, the next-generation fractional CO₂ laser eCO2 3D, and the monopolar RF device XERF. Following its strategic merger led by Hahn & Company in 2024, Cynosure Lutronic now operates in approximately 130 countries, holds over 535 patents, and commands the industry's largest EBD portfolio. Speaking on-site in Paris, Hauke Harms, President of International, stated, "We will demonstrate the competitiveness of the industry's largest portfolio by launching three new products in the EMEA and Latin American markets."
#MedicalAestheticNews #IMCAS2026 #CynosureLutronic #Mosaic3D #eCO23D #XERF
★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11208

Comments
Post a Comment